BelPi Genetics: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
BelPi Genetics
Largest movements
- Cash -€29,913
down €29,913 (-45.2%), from €66,199 to €36,286
mainly Net result for the year (-€14,587) and Other debts (-€13,348)
- Tangible fixed assets -€3,060
down €3,060 (-19.7%), from €15,553 to €12,493
- Intangible fixed assets +€1,746
new in 2025: €1,746
- Receivables within one year -€1,741
down €1,741 (-9.7%), from €18,023 to €16,282
of which Other amounts receivable: -€7,846
- Profit (loss) carried forward -€14,587
down €14,587 (-24.2%), from €60,266 to €45,680
- Other debts -€13,348
down €13,348 (-100.0%), from €13,348 to €0
- Trade debts -€5,034
down €5,034 (-22.9%), from €21,961 to €16,927
- Gross operating margin -€7,120
down €7,120 (-240.2%), from -€2,964 to -€10,084
- Financial charges +€549
up €549 (+406.4%), from €135 to €684
- Other operating charges -€164
down €164 (-19.3%), from €848 to €684
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €99,776 | €66,806 | -€32,969 | -33.0% |
| Fixed assets | 21/28 | €15,553 | €14,238 | -€1,315 | -8.5% |
| Intangible fixed assets | 21 | - | €1,746 | +€1,746 | |
| Tangible fixed assets | 22/27 | €15,553 | €12,493 | -€3,060 | -19.7% |
| Plant, machinery and equipment | 23 | €15,553 | €12,493 | -€3,060 | -19.7% |
| Current assets | 29/58 | €84,222 | €52,568 | -€31,655 | -37.6% |
| Amounts receivable within one year | 40/41 | €18,023 | €16,282 | -€1,741 | -9.7% |
| Trade receivables | 40 | €9,670 | €15,775 | +€6,105 | +63.1% |
| Other amounts receivable | 41 | €8,353 | €507 | -€7,846 | -93.9% |
| Cash at bank and in hand | 54/58 | €66,199 | €36,286 | -€29,913 | -45.2% |
| Total equity and liabilities | 10/49 | €99,776 | €66,806 | -€32,969 | -33.0% |
| Equity | 10/15 | €64,466 | €49,880 | -€14,587 | -22.6% |
| Contributions | 10/11 | €4,200 | €4,200 | = | 0.0% |
| Profit (loss) carried forward | 14 | €60,266 | €45,680 | -€14,587 | -24.2% |
| Amounts payable | 17/49 | €35,309 | €16,927 | -€18,383 | -52.1% |
| Amounts payable within one year | 42/48 | €35,309 | €16,927 | -€18,383 | -52.1% |
| Trade debts | 44 | €21,961 | €16,927 | -€5,034 | -22.9% |
| Suppliers | 440/4 | €21,961 | €16,927 | -€5,034 | -22.9% |
| Taxes, remuneration and social security | 45 | €0 | - | = | |
| Taxes | 450/3 | €0 | - | = | |
| Other amounts payable | 47/48 | €13,348 | €0 | -€13,348 | -100.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €3,060 | €3,135 | +€74 | +2.4% |
| Other operating charges | 640/8 | €848 | €684 | -€164 | -19.3% |
| Gross operating margin | 9900 | -€2,964 | -€10,084 | -€7,120 | -240.2% |
| Operating profit (loss) | 9901 | -€6,872 | -€13,903 | -€7,031 | -102.3% |
| Financial income | 75/76B | €0 | - | = | |
| Recurring financial income | 75 | €0 | - | = | |
| Financial charges | 65/66B | €135 | €684 | +€549 | +406.4% |
| Recurring financial charges | 65 | €135 | €684 | +€549 | +406.4% |
| Profit (loss) for the period before taxes | 9903 | -€7,007 | -€14,587 | -€7,580 | -108.2% |
| Income taxes | 67/77 | €0 | - | = | |
| Profit (loss) for the period | 9904 | -€7,007 | -€14,587 | -€7,580 | -108.2% |
| Profit (loss) for the period to be appropriated | 9905 | -€7,007 | -€14,587 | -€7,580 | -108.2% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 11 October 2026 via checked.be.